Intelligence · Patents
Patents expiring in 2042
Annual patent cliff calendar for 2042 — US pharmaceutical patents by expiration date.
- Patents
- 1,738
Quick answer
1,738 indexed pharmaceutical patents have expiration dates in 2042. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 11338118
Swallowable drug delivery device and methods of drug delivery
granted -
US 11338032
Methods of preparing anti-human papillomavirus antigen T cells
granted -
US 11337998
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11337989
Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
granted -
US 11337988
Use of ouabain antagonists to inhibit viral infection
granted -
US 11337941
Inhibitors and their uses
granted -
CA 3198740
METHODES DE TRAITEMENT D'UN REJET A MEDIATION PAR ANTICORPS
granted -
CA 3198544
PROCEDES D'AUGMENTATION DE LA TAILLE ET DE PROMOTION DE LA CROISSANCE OSSEUSE LINEAIRE
granted -
US 11344538
Methods for the treatment of myopia
granted -
US 11344559
PI3KGAMMA inhibitors
granted -
US 11344605
Therapeutic use of inhibitors of t cell activation or stimulation
granted -
US 11344610
Prevention and reduction of blood loss
granted -
US 11344618
HIV envelope glycoprotein immunogens
granted -
US 11344491
Compositions and methods of using the same for decontamination of skin
granted -
US 11344526
Implantable drug delivery devices for localized drug delivery
granted -
US 11345733
Colon and pancreas cancer specific antigens and antibodies
granted -
US 11345678
Benzopyrazole compound used as RHO kinase inhibitor
granted -
US 11344579
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11344569
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 11344575
Vascular calcification prevention and treatment
granted -
US 11344514
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 11344555
Nucleotide analogs
granted -
US 11344557
Corticotropin releasing factor receptor antagonists
granted -
US 11344578
Immune cells expressing engineered antigen receptors
granted -
US 11344609
Compositions and methods for treating hemoglobinopathies
granted -
US 11345734
Chimeric T cell
granted -
US 11345653
Compositions and methods for reactivating cholinesterases
granted -
US 11344652
Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
granted -
US 11344581
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11345658
Compounds and compositions comprising the same for treating hypertension or heart failure
granted -
US 11344631
Promoter for cell-specific gene expression and uses thereof
granted -
US 11345930
Codon optimized RPGRORF15 genes and uses thereof
granted -
US 11345904
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
granted -
US 11344707
Devices for applying a topical treatment
granted -
US 11345659
Pipecolic esters for inhibition of the proteasome
granted -
US 11345702
PGDH inhibitors and methods of making and using
granted -
US 11345928
Modified immunization vectors
granted -
US 11345715
Biologically active molecules, conjugates thereof, and therapeutic uses
granted -
US 11345700
Methods of preparing inhibitors of influenza viruses replication
granted -
US 11345694
Antibacterial compounds
granted -
US 11344626
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
granted -
US 11344615
Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells
granted -
US 11344580
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11344568
Methods and compositions for administration of iron
granted -
US 11344513
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11345705
Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists
granted -
US 11345894
Cellular seeding and co-culture of a three dimensional fibroblast construct
granted
Frequently asked questions
How many pharma patents expire in 2042?
1,738 published patents in our USPTO index have expiration dates falling in calendar year 2042.